Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 26,954 shares at $150.23 ($4.0M) on 2025-07-10, disclosed to the SEC on 2025-07-11.
Scheduled sale ($4.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.07 | 200 | $30K | 0.7% |
| 2 | $150.14 | 200 | $30K | 0.7% |
| 3 | $150.22 | 6,627 | $996K | 24.6% |
| 4 | $150.22 | 6,627 | $996K | 24.6% |
| 5 | $150.23 | 6,500 | $976K | 24.1% |
| 6 | $150.23 | 6,500 |
| $976K |
| 24.1% |
| 7 | $151.39 | 300 | $45K | 1.1% |
| Total | $150.24 avg | 26,954 | $4.0M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |